Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:alsoKnownAs |
Analogue Act
|
| gptkbp:appliesTo |
intended for human consumption
substances substantially similar to Schedule I or II drugs |
| gptkbp:codifiedIn |
21 U.S.C. § 813
|
| gptkbp:dateEnacted |
1986
|
| gptkbp:defines |
controlled substance analogue
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:enforcedBy |
gptkb:Drug_Enforcement_Administration
|
| https://www.w3.org/2000/01/rdf-schema#label |
Federal Analog Act
|
| gptkbp:legalSystem |
substantially similar in chemical structure and effect
|
| gptkbp:partOf |
gptkb:Controlled_Substances_Act
|
| gptkbp:penalty |
same as controlled substance being mimicked
|
| gptkbp:purpose |
regulate controlled substance analogues
|
| gptkbp:relatedTo |
Designer drugs
Synthetic drugs |
| gptkbp:bfsParent |
gptkb:Controlled_Substances_Act_of_1970
|
| gptkbp:bfsLayer |
7
|